Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2020, it served 43 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
IPO Year:
Exchange: NYSE
Website: antheminc.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/22/2022 | $607.00 → $533.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/17/2022 | $550.00 | Buy | Loop Capital |
| 5/27/2022 | $577.00 → $596.00 | Outperform | Bernstein |
| 2/7/2022 | $475.00 → $500.00 | Buy | Argus Research |
| 1/28/2022 | $561.00 → $518.00 | Overweight | Morgan Stanley |
| 1/27/2022 | $430.00 → $465.00 | Market Perform | SVB Leerink |
| 12/20/2021 | $450.00 → $510.00 | Neutral → Buy | Mizuho |
| 12/17/2021 | $486.00 → $561.00 | Overweight | Morgan Stanley |
| 12/14/2021 | $517.00 | Buy | Goldman |
| 10/29/2021 | $385.00 → $450.00 | Neutral | Mizuho |
SC 13G/A - Anthem, Inc. (0001156039) (Subject)
SC 13G/A - Anthem, Inc. (0001156039) (Subject)
PONTE VEDRA, Fla., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced the appointment of Betsy Hanna and Deepti Jain to its Board of Directors effective October 1, 2021. "With decades of combined experience in healthcare leadership, Ms. Hanna and Ms. Jain strengthen the expertise of our Company's Board of Directors," said James T. Treace, the Company's Chairman of the Board. "Our executive leadership and board are pleased to add two individuals with their stellar reputa
MINNEAPOLIS, Aug. 11, 2021 /PRNewswire/ -- Target Corporation (NYSE:TGT) announced today its board of directors elected David P. Abney, former chairman of the board and chief executive officer of United Parcel Service, Inc., and Gail K. Boudreaux, president and chief executive officer of Anthem, Inc., as directors. Mr. Abney's appointment is effective immediately and Ms. Boudreaux's appointment becomes effective September 23, 2021. Mr. Abney, 65, held a series of escalating leadership roles at UPS over his more than 40-year career. He was named CEO in September 2014 and chairman and CEO in February 2016, a role he held until announcing his retirement in June 2020. He remained executive chair
CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Mark Morgan as a board member. Mark is the SVP of Market Access for GRAIL, which has developed a highly innovative multi-cancer, early detection blood test. "We are excited to welcome Mark Morgan to the Dante Labs Board," said Dante Labs CEO Andrea Riposati, "Mark is a rockstar in healthcare. His deep experience with health plans, coupled with market access expertise in both biopharma and diagnostics will be invaluable to Dante Labs as we continue to build on our global success and expansion in the United States." Mr. Morgan state
Morgan Stanley downgraded Anthem from Overweight to Equal-Weight and set a new price target of $533.00 from $607.00 previously
Loop Capital initiated coverage of Anthem with a rating of Buy and set a new price target of $550.00
Bernstein resumed coverage of Anthem with a rating of Outperform and set a new price target of $596.00 from $577.00 previously
Argus Research reiterated coverage of Anthem with a rating of Buy and set a new price target of $500.00 from $475.00 previously
Morgan Stanley reiterated coverage of Anthem with a rating of Overweight and set a new price target of $518.00 from $561.00 previously
SVB Leerink reiterated coverage of Anthem with a rating of Market Perform and set a new price target of $465.00 from $430.00 previously
Mizuho upgraded Anthem from Neutral to Buy and set a new price target of $510.00 from $450.00 previously
Morgan Stanley reiterated coverage of Anthem with a rating of Overweight and set a new price target of $561.00 from $486.00 previously
Goldman initiated coverage of Anthem with a rating of Buy and set a new price target of $517.00
Mizuho reiterated coverage of Anthem with a rating of Neutral and set a new price target of $450.00 from $385.00 previously
Changes reflect the company's continued evolution to support whole health As Anthem, Inc. (ANTM) moves closer to rebranding to Elevance Health, Inc. later this month, the company today announced the launch of healthcare services brand Carelon and health plan brand Wellpoint to join the company's family of brands that includes Anthem Blue Cross and Blue Shield. The move will optimize and streamline the company's brand portfolio, reduce complexities, and further underscore its evolution to deliver solutions beyond traditional health insurance, simplify the healthcare experience, and advance health beyond healthcare. "An important part of being a lifetime, trusted health partner is grounded
Anthem partners with Happify Health to bring innovative digital health services to areas of women's health including pregnancy, menopause, and more Anthem, Inc. (NYSE:ANTM), a leading health company dedicated to improving lives and communities, will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets. This program, a collaboration between Anthem – soon to be Elevance Health on June 28 – and Happify Health, bridges the gap between the unique physical and mental health concerns women face. It is part of Anthem's early and consistent support of women throughout the entirety of their maternal health journey with solution
Anthem, Inc. (NYSE:ANTM) announced today that senior management is scheduled to present at the 38th Annual Bernstein Strategic Decisions Conference in New York City on June 3, at 8:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of the presentation by visiting www.antheminc.com and selecting the "Investors" link. Following the presentation, a webcast replay will be available for two weeks. To listen to the live webcast, please visit Anthem's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Anthem's most recent filings with the SEC,
Anthem, Inc. (NYSE:ANTM) today announced the completion of its acquisition of Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. "We're pleased to complete this acquisition and work alongside our new colleagues as we continue to grow our Medicaid business and enhance the healthcare experience for all of our members," said Felicia Norwood, Executive Vice President of Anthem's Government Business Division. "Anthem and Integra's shared commitment to deliver high quality, comprehensive whole-health care across communities throughout New York ensures that our members will c
Anthem, Inc. (NYSE:ANTM) announced today that senior management is scheduled to present at the Bank of America Healthcare Conference in Las Vegas, Nevada on May 11, at 2:40 p.m. Pacific Time (PT) / 5:40 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a webcast of the presentation by visiting www.antheminc.com and selecting the "Investors" link. Following the presentation, a webcast replay will be available for two weeks. To listen to the live webcast, please visit Anthem's website at least 15 minutes early to download and install any necessary audio software. Individuals who listen to the presentations will be presumed to have read Anthem's most recent fil
First quarter GAAP net income was $7.39 per share, including net negative adjustment items of $0.86 per share. Adjusted net income was $8.25* per share. Operating revenue grew by 18.0% over the prior year quarter to $37.9 billion. Operating gain grew by 13.2% over the prior year quarter to $2.4 billion. Medical enrollment increased by 3.3 million members year-over-year and 1.4 million members sequentially to 46.8 million members. Second quarter 2022 dividend of $1.28 per share declared to shareholders. Anthem, Inc. (NYSE:ANTM) reported first quarter 2022 results reflecting strong financial performance, including double-digit top and bottom line growth. "Our strong momentum a
Anthem, Inc. (NYSE:ANTM) will release first quarter 2022 financial results on April 20, 2022, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-813-5525 (Domestic Replay) 312-470-0178 (International) 203-369-3346 (International Replay) The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on April 20, 2022 until the end of the day on May 20, 2022. The cal
New Holding Company Name, Elevance Health, Reflects Focus to Elevate Health and Advance Healthcare Anthem, Inc. (NYSE:ANTM) today announced its intent to change its name to better reflect the company's business and its bold purpose of improving the health of humanity. Anthem intends to become Elevance Health, Inc., subject to shareholder approval. The new name underscores the company's commitment to elevating whole health and advancing health beyond healthcare. "Improving health means more than just treating what ails us. We must address whole health and the physical, behavioral, and social drivers that impact it," said Anthem President and CEO Gail Boudreaux. "This need has driven our tr
AM Best has assigned a Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of "a-" (Excellent) to WellPoint Insurance Services, Inc. (WISI) (Honolulu, HI). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect WISI's balance sheet strength, which AM Best assesses as adequate, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. In addition, the rating takes into account the support provided by WISI's parent, Anthem, Inc. (Anthem) (NYSE:ANTM). WISI's risk-adjusted capitalization, as measured by Best Capital Adequacy Ratio (BCAR), was at the stron
Transaction Comes as LIBERTY Seeks to Fast-Track Investments, Expand Unique Dental Care Management Model and Accelerate Growth LIBERTY Dental Plan Corporation (LIBERTY) and Welsh, Carson, Anderson & Stowe (WCAS) today announced the parties have entered into a definitive agreement through which WCAS will make an equity investment and become the majority investor in LIBERTY. Anthem, Inc. (NYSE:ANTM), a leading health company and a LIBERTY customer since 2010, will also become a minority investor. Terms of the agreement were not disclosed. This agreement with WCAS, a healthcare and technology-focused investment firm, will enable LIBERTY to expand into additional markets and serve a greater n
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Elevance Health, Inc. (0001156039) (Issuer)
3 - Elevance Health, Inc. (0001156039) (Issuer)
4 - Anthem, Inc. (0001156039) (Issuer)
4 - Anthem, Inc. (0001156039) (Issuer)
Anthem, Inc. (NYSE:ANTM) today announced the completion of its acquisition of Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. "We're pleased to complete this acquisition and work alongside our new colleagues as we continue to grow our Medicaid business and enhance the healthcare experience for all of our members," said Felicia Norwood, Executive Vice President of Anthem's Government Business Division. "Anthem and Integra's shared commitment to deliver high quality, comprehensive whole-health care across communities throughout New York ensures that our members will c
First quarter GAAP net income was $7.39 per share, including net negative adjustment items of $0.86 per share. Adjusted net income was $8.25* per share. Operating revenue grew by 18.0% over the prior year quarter to $37.9 billion. Operating gain grew by 13.2% over the prior year quarter to $2.4 billion. Medical enrollment increased by 3.3 million members year-over-year and 1.4 million members sequentially to 46.8 million members. Second quarter 2022 dividend of $1.28 per share declared to shareholders. Anthem, Inc. (NYSE:ANTM) reported first quarter 2022 results reflecting strong financial performance, including double-digit top and bottom line growth. "Our strong momentum a
Anthem, Inc. (NYSE:ANTM) will release first quarter 2022 financial results on April 20, 2022, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-813-5525 (Domestic Replay) 312-470-0178 (International) 203-369-3346 (International Replay) The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on April 20, 2022 until the end of the day on May 20, 2022. The cal
AM Best has assigned a Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of "a-" (Excellent) to WellPoint Insurance Services, Inc. (WISI) (Honolulu, HI). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect WISI's balance sheet strength, which AM Best assesses as adequate, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. In addition, the rating takes into account the support provided by WISI's parent, Anthem, Inc. (Anthem) (NYSE:ANTM). WISI's risk-adjusted capitalization, as measured by Best Capital Adequacy Ratio (BCAR), was at the stron
Transaction Comes as LIBERTY Seeks to Fast-Track Investments, Expand Unique Dental Care Management Model and Accelerate Growth LIBERTY Dental Plan Corporation (LIBERTY) and Welsh, Carson, Anderson & Stowe (WCAS) today announced the parties have entered into a definitive agreement through which WCAS will make an equity investment and become the majority investor in LIBERTY. Anthem, Inc. (NYSE:ANTM), a leading health company and a LIBERTY customer since 2010, will also become a minority investor. Terms of the agreement were not disclosed. This agreement with WCAS, a healthcare and technology-focused investment firm, will enable LIBERTY to expand into additional markets and serve a greater n
Fourth quarter GAAP net income was $4.63 per share, including net negative adjustment items of $0.51 per share. Adjusted net income was $5.14* per share. Full year GAAP net income was $24.73 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $25.98* per share. Fourth quarter operating revenue grew by 14.2% over the prior year quarter to $36.0 billion. Full year operating revenue grew 13.4% year-over-year to $136.9 billion. Medical enrollment increased by 2.4 million members year-over-year and 303 thousand members in the fourth quarter to 45.4 million members. Full year 2022 GAAP net income is expected to be greater than $26.75 per
Anthem, Inc. (NYSE:ANTM) will release fourth quarter 2021 financial results on January 26, 2022, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 (Domestic) 800-570-8796 (Domestic Replay) 312-470-0178 (International) 203-369-3293 (International Replay) The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EST on January 26, 2022 until the end of the day on February 25, 2022.
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of "a+" (Excellent) of the core Blue Cross Blue Shield-branded insurance subsidiaries of Anthem, Inc. (Anthem) (Indianapolis, IN) (NYSE:ANTM), as well as its branded life insurance subsidiaries. Concurrently, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to "a+" (Excellent) from "a-" (Excellent) of various AMERIGROUP affiliates. All companies listed above are collectively referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+" (Good), the Long- and Short-Term Issue Credit Ratings (L
Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into an agreement to acquire Integra Managed Care, a Managed Long-Term Care Plan in New York that helps adults with long term care needs and disabilities live safely and independently in their own home. Integra currently serves 40,000 Medicaid members who benefit from a dedicated care management team that includes a Registered Nurse, Social Worker, and Coordinator who work in partnership with members, their families, and health care providers to ensure their long-term care needs are met. "This acquisition aligns with our goal of growing Anthem's Medicaid business, while serving our members with a comprehensive and coord
Third quarter GAAP net income was $6.13 per share, including net negative adjustment items of $0.66 per share. Adjusted net income was $6.79* per share. Operating revenue grew by 16.0% over the prior year quarter to $35.5 billion, or 17.5% adjusted for the repeal of the health insurance tax. Medical enrollment increased by 2.4 million members year over year and 730 thousand members in the third quarter to 45.1 million members. Fourth quarter 2021 dividend of $1.13 per share declared to shareholders. Raising full year adjusted net income outlook from greater than $25.50* per share to greater than $25.85* per share. Anthem, Inc. (NYSE:ANTM) reported third quarter 2021 results refle
8-K - Elevance Health, Inc. (0001156039) (Filer)
424B3 - Elevance Health, Inc. (0001156039) (Filer)
FWP - Elevance Health, Inc. (0001156039) (Subject)
424B3 - Elevance Health, Inc. (0001156039) (Filer)
8-K - Elevance Health, Inc. (0001156039) (Filer)
10-Q - Elevance Health, Inc. (0001156039) (Filer)
8-K - Elevance Health, Inc. (0001156039) (Filer)
10-Q - Elevance Health, Inc. (0001156039) (Filer)
8-K - Elevance Health, Inc. (0001156039) (Filer)
8-K - Elevance Health, Inc. (0001156039) (Filer)
Anthem (NYSE:ANTM) has outperformed the market over the past 5 years by 10.2% on an annualized basis producing an average annual return of 20.15%. Currently, Anthem has a market capitalization of $113.14 billion. Buying $1000 In ANTM: If an investor had bought $1000 of ANTM stock 5 years ago, it would be worth $2,494.58 today based on a price of $469.31 for ANTM at the time of writing. Anthem's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed
Wall Street has officially fallen into a bear market as investor sentiment is hammered by soaring inflation, rising interest rates and worries about a looming recession in the world’s largest economy. A bear market occurs when a stock index like the S&P 500 falls by 20% over a sustained period from a recent high. Conversely, a bull market happens when stocks rise 20% from a recent low. On June 13, the S&P closed in bear market territory for the first time since March 2020, as it slipped 3.9% to 3,749.63, its lowest since March 2020, and the second bear market of the pandemic era. The S&P sank deeper on Thursday, June 16, to close at a new low since December 2020. 2020 market crash T
Upgrades RBC Capital upgraded the previous rating for SiteOne Landscape Supply Inc (NYSE:SITE) from Underperform to Sector Perform. In the first quarter, SiteOne Landscape Supply showed an EPS of $0.70, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $260.00 and a 52-week-low of $108.77. SiteOne Landscape Supply closed at $112.24 at the end of the last trading period. JP Morgan upgraded the previous rating for Brixmor Property Group Inc (NYSE:BRX) from Neutral to Overweight. In the first quarter, Brixmor Property Group showed an EPS of $0.49, compared to $0.44 from the year-ago quarter. The current stock performance of Brixmor Property Group sho
Morgan Stanley analyst Ricky Goldwasser downgrades Anthem (NYSE:ANTM) from Overweight to Equal-Weight and lowers the price target from $607 to $533.
Anthem (NYSE:ANTM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 5 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 2 0 0 0 2M Ago 2 3 1 0 0 3M Ago 1 0 0 0 0 These 10 analysts have an average price target of $581.7 versus the current price of Anthem at $458.27, implying upside. Below is a summary of how these 10 analysts rated Anthem over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock This average price target has increased by 13.45% ove
Loop Capital analyst Joseph France initiates coverage on Anthem (NYSE:ANTM) with a Buy rating and announces Price Target of $550.
- Reuters
Anthem (NYSE:ANTM) has outperformed the market over the past 5 years by 10.47% on an annualized basis producing an average annual return of 21.3%. Currently, Anthem has a market capitalization of $118.50 billion. Buying $100 In ANTM: If an investor had bought $100 of ANTM stock 5 years ago, it would be worth $263.22 today based on a price of $491.54 for ANTM at the time of writing. Anthem's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed by a
Anthem (NYSE:ANTM) has outperformed the market over the past 20 years by 7.36% on an annualized basis producing an average annual return of 14.44%. Currently, Anthem has a market capitalization of $124.10 billion. Buying $1000 In ANTM: If an investor had bought $1000 of ANTM stock 20 years ago, it would be worth $14,651.34 today based on a price of $514.77 for ANTM at the time of writing. Anthem's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and revie
Analysts have provided the following ratings for Anthem (NYSE:ANTM) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 5 2 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 3 3 1 0 0 3M Ago 0 0 1 0 0 According to 10 analyst offering 12-month price targets in the last 3 months, Anthem has an average price target of $575.0 with a high of $625.00 and a low of $483.00. Below is a summary of how these 10 analysts rated Anthem over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock